Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor

US6835381B1 · kind B1 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Gabi Friedrich · Leverkusen, DE
• Gustav Hagen · Leverkusen, DE
• Maresa Wick · Berlin, DE
• Dmitry Zubov · Remscheid, DE
• Nathalie Dubois-Stringfellow · Berkeley, US

Key dates

• Filing date: May 17, 2002
• Grant date: Dec 28, 2004
• Expiry date: May 30, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/1891
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides methods for modulating angiogenesis by administering anti-angiogenic Ang-7 polypeptides to a subject. Methods of modulating angiogenesis by administering an anti-angiogenic ANG-7 nucleic acid are also provided.